Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Heart closure devices industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Product trends
2.5 Material trends
2.6 Mode of delivery trends
2.7 End-use trends
Chapter 3 Heart Closure Devices Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing prevalence of cardiovascular diseases
3.2.1.2 Technological advancements
3.2.1.3 Rising preference for minimally invasive procedures
3.2.1.4 Favorable reimbursement policies
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory policies
3.2.2.2 Potential complications and adverse events
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By material
3.3.3 By mode of delivery
3.3.4 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Reimbursement scenario
3.7 Pricing analysis, 2022
3.8 Technology landscape
3.9 Future market trends
3.10 Gap analysis
3.11 Porter’s analysis
3.12 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company market share analysis, 2022
4.4 Competitive positioning matrix
4.5 Vendor matrix analysis
4.6 Strategy dashboard, 2022
Chapter 5 Heart Closure Devices Market Size and Forecast, By Product (USD Million & Units)
5.1 Key product trends
5.2 Atrial Septal Defect (ASD) Closure Devices
5.3 Ventricular Septal Defect (VSD) Closure Devices
5.4 Patent Foramen Ovale (PFO) Closure Devices
5.5 Left Atrial Appendage (LAA) Closure Devices
5.6 Others
Chapter 6 Heart Closure Devices Market Size and Forecast, By Material (USD Million)
6.1 Key material trends
6.2 Nitinol-based Devices
6.3 Stainless Steel Devices
6.4 Others
Chapter 7 Heart Closure Devices Market Size and Forecast, By Mode of Delivery (USD Million)
7.1 Key mode of delivery trends
7.2 Transcatheter Delivery
7.3 Surgical Delivery
Chapter 8 Heart Closure Devices Market Size and Forecast, By End-use (USD Million)
8.1 Key end-use trends
8.2 Hospitals
8.3 Ambulatory Surgical Centers (ASCs)
8.4 Cardiac Catheterization Laboratories
8.5 Others
Chapter 9 Heart Closure Devices Market Size and Forecast, By Region (USD Million & Units)
9.1 Key regional trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Poland
9.3.7 Sweden
9.3.8 The Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Indonesia
9.4.7 Philippines
9.4.8 Vietnam
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Columbia
9.5.5 Chile
9.5.6 Peru
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Turkey
9.6.5 Iran
9.6.6 Israel
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 AtriCure Inc.
10.3 Biosense Webster, Inc.
10.4 Boston Scientific Corporation
10.5 Cardia, Inc.
10.6 Heartstitch
10.7 Lepu Medical Technology (Beijing)Co., Ltd.
10.8 LifeTech Scientific Corporation
10.9 Medtronic Plc.
10.10 Occlutech
10.11 SentreHEART, Inc.
10.12 Starway Medical Technology, Inc.
10.13 W. L. Gore & Associates, Inc.
